Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1

Status

Recruiting 2Not yet recruiting 2Completed 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5Observational 4

Sponsor

Cancer Type

Gynecologic 5

Conditions

Breast Neoplasms 434Carcinoma, Non-Small-Cell Lung 360Neoplasms 339Prostatic Neoplasms 276Colorectal Neoplasms 264Multiple Myeloma 206Lung Neoplasms 195Neoplasm Metastasis 179Leukemia, Myeloid, Acute 160Ovarian Neoplasms 155Pancreatic Neoplasms 152Squamous Cell Carcinoma of Head and Neck 138Melanoma 126Recurrence 104Head and Neck Neoplasms 99Glioblastoma 99Carcinoma, Renal Cell 98Endometrial Neoplasms 96Carcinoma, Hepatocellular 93Lymphoma, Non-Hodgkin 92Precursor Cell Lymphoblastic Leukemia-Lymphoma 91Lymphoma 91Triple Negative Breast Neoplasms 90Stomach Neoplasms 88Uterine Cervical Neoplasms 85Brain Neoplasms 85Lymphoma, Large B-Cell, Diffuse 80Urinary Bladder Neoplasms 77Glioma 74Leukemia, Lymphocytic, Chronic, B-Cell 73

Interventions

epigallocatechin gallate 1Watchful Waiting 1Transurethral Resection of Prostate 1Acetic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Uterine Cervical Dysplasia × 30 days × Clear all
NCT07545746 2026-06-02

ASCEND

UNC Lineberger Comprehensive Cancer Center

Phase 2 Not yet recruiting
140 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

NCT06519994 2026-05-14

Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya

UNC Lineberger Comprehensive Cancer Center

Phase 2 Completed
120 enrolled
Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia

NCT07572396 2026-05-14

Phase II Study of Dysplasixâ„¢ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

Amplexd Therapeutics, Inc.

Phase 2 Recruiting
45 enrolled
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

NCT07576842 2026-05-08

Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV

University of California, San Diego

Phase NA Not yet recruiting
750 enrolled
Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT07454915 2026-05-06

PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia

PapiVax Biotech, Inc.

Phase 2 Recruiting
138 enrolled
Gynecologic

Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡